Abstract
A modified AFLP (amplified fragment length polymorphism) method was employed to isolate genes differentially expressed in renal carcinogenesis of Tsc2 gene mutant (Eker) rats. One gene, selected for further investigation, was named ″Niban″ (″second″ in Japanese), because it is the second new gene to be found after Erc (expressed in renal carcinoma) in our laboratory. Importantly, ″Niban″ is well expressed even in small primary rat Eker renal tumors, more than in progressed cell lines, and is also expressed in human renal carcinoma cells, but not in normal human or rat kidneys. Chromosome assignment was to RNO 13 in the rat, and HSA 1. This ″Niban″ gene is a candidate as a marker for renal tumor, especially early-stage renal carcinogenesis.
| Original language | English |
|---|---|
| Pages (from-to) | 869-874 |
| Number of pages | 6 |
| Journal | Japanese Journal of Cancer Research |
| Volume | 91 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - 2000 |
Keywords
- CDNA-AFLP
- Multistep renal carcinogenesis
- Tsc2 gene mutant (Eker) rats
- Tumor marker
ASJC Scopus subject areas
- Oncology
- Cancer Research
Fingerprint Dive into the research topics of 'A novel gene ″Niban″ upregulated in renal carcinogenesis: Cloning by the cDNA-amplified fragment length polymorphism approach'. Together they form a unique fingerprint.
Cite this
Majima, S., Kajino, K., Fukuda, T., Otsuka, F., & Hino, O. (2000). A novel gene ″Niban″ upregulated in renal carcinogenesis: Cloning by the cDNA-amplified fragment length polymorphism approach. Japanese Journal of Cancer Research, 91(9), 869-874. https://doi.org/10.1111/j.1349-7006.2000.tb01027.x